Lightlake Therapeutics Inc (LLTP.PK)

LLTP.PK on OTC Markets Group

7.30USD
2 Jul 2015
Change (% chg)

$-0.20 (-2.67%)
Prev Close
$7.50
Open
$7.50
Day's High
$7.65
Day's Low
$7.30
Volume
2,989
Avg. Vol
2,810
52-wk High
$10.99
52-wk Low
$2.26

LLTP.PK

Chart for LLTP.PK

About

Lightlake Therapeutics, Inc. (Lightlake) is an early stage biopharmaceutical company. Lightlake is focused on developing a treatment to reverse opioid overdoses, a treatment for overweight and obese patients with binge eating disorder and a treatment for patients with Bulimia Nervosa. Lightlake has completed a clinical trial for... (more)
No analyst recommendations are available for LLTP.PK.

Overall

Beta: 5.09
Market Cap(Mil.): $13.49
Shares Outstanding(Mil.): 1.85
Dividend: --
Yield (%): --

Financials

  LLTP.PK Industry Sector
P/E (TTM): -- 35.83 39.81
EPS (TTM): -5.31 -- --
ROI: -- 17.03 16.23
ROE: -- 17.93 17.36
Search Stocks

Earnings vs. Estimates

No consensus analysis data available.

Analyst Research Reports

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks